P2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand

Ying-mei Lu1, Rong-rong Tao, Ji-yun Huang

  • 1Department of Neurobiology, Key Laboratory of Medical Neurobiology of Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, China.

Abstract

Insights

Microglia-derived FasL, regulated by P2X7 signaling, exacerbates brain injury after stroke. Inhibiting this P2X7-FasL pathway reduces microglial activation and neuronal death, offering potential stroke therapies.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Cerebral microvascular occlusion causes stroke-like injury, but mechanisms remain unclear.
  • The Fas ligand (FasL)-Fas system is implicated in various diseases.
  • This study investigates microglia-derived FasL's role in inflammatory brain injury during ischemia.

Purpose of the Study:

  • To examine the contribution of microglia-derived FasL to brain inflammatory injury.
  • To explore the potential of inhibiting P2X7-FasL signaling to suppress FasL increase during ischemia.
  • To investigate pharmacological and genetic approaches for P2X7-FasL inhibition.

Main Methods:

  • Cerebral microvascular occlusion induced by microsphere injection in experimental animals.
  • Immunohistochemical analysis of microglial morphology and P2X7/FasL signaling.
  • Utilized BV-2 cells and primary microglia from P2X7-deficient mice.

Main Results:

  • FasL expression increased with microglia activation post-embolism, correlating with P2X7 expression in microglia.
  • Silencing P2X7 prevented FasL generation in microglia under oxygen-glucose deprivation.
  • FasL neutralization inhibited ischemia-induced microglial migration; P2X7(-/-) mice showed reduced FasL and neuronal death.

Conclusions:

  • FasL, via a P2X7-dependent mechanism, recruits microglia to lesion sites, forming an immunoreactive response loop.
  • Modulating P2X7/FasL signaling and microglial activation may offer therapeutic benefits for cerebral microembolic injury.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...